US Stock Market Movement: Mirum surges on October 9 as AZURE-1 meets criteria and receives FDA approval
Bitget异动解读2026/10/09 16:45Mirum October 9th Surge Interpretation
Keywords: AZURE-1 Achieved, FDA Approval
1. On September 28, the company announced that the AZURE-1 Phase III study of breলovitug met the primary endpoint at week 24 in both dosing groups. Data from week 48 in the Phase II study showed deeper viral suppression and a higher rate of ALT normalization, with no new safety signals observed. The company plans to submit a BLA application in the first half of 2027.
2. On September 25, the company and Incyte announced that Atebrioz received approval from the U.S. FDA to reduce new heterotopic ossification volume in FOP patients aged 12 and above. The drug is expected to launch in the U.S. in October, and Mirum holds the global development and commercialization rights.
3. On October 8, RBC Capital Markets raised Mirum's target price from $135 to $155 and maintained its “Outperform” rating.
(Disclaimer: This content is generated by AI technology summarizing publicly available information and is for reference only. It does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Apple adjusts 2026 fall new device orders, increases iPhone Duo order by 30%
ASML to raise prices of equipment parts in Korea by 10% starting January next year
According to Korean media reports, ASML, the world’s largest semiconductor equipment manufacturer, will implement a uniform 10% price increase on replacement parts for equipment supplied in Korea. The new prices will take effect starting from January next year, and the increase covers all components of both EUV and DUV lithography machines. Industry insiders revealed that in early last month, ASML's headquarters had already expressed its intention to raise prices to Samsung Electronics and SK Hynix through its Korean branch. The adjustment was finalized after negotiations with the procurement departments of both companies.